EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Challenges and Future Trends in Large Vessel Vasculitis

Maria Sandovici iD, Kornelis S M van der Geest iD, Rosanne D Reitsema iD, Neeraj Dhaun iD, Taryn Youngstein iD, Alexandre Wagner Silva de Souza iD, Peter C Grayson, Berit D Nielsen, Marc R Dweck iD, Ellen Hendrikse iD, Andor W J M Glaudemans iD, Elisabeth Brouwer iD und 1 weitere

Circulation · 23.06.2026 · 153 (25) · 2064-2083

DOI: 10.1161/circulationaha.125.077491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 23.06.2026. Verfasst von Maria Sandovici und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology (M.S., K.S.M.v.d.G., E.B.), University of Groningen, University Medical Centre Groningen, The Neth…. Hauptthemen laut MEDLINE: Giant Cell Arteritis, Takayasu Arteritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the Chapel Hill consensus criteria, the primary forms of vasculitis are classified by the predominant size of the affected blood vessels into large, medium, or small vessels. The two main forms of large vessel vasculitis (LVV) are giant cell arteritis and Takayasu arteritis, both of which are more prevalent in women while showing distinct geographic patterns of prevalence. The pathogenesis of LVV is complex and multifactorial, involving a combination of genetic predisposition, environmental and geographic triggers, immune dysregulation, and aging or (premature) senescence of the immune system and blood vessels. Diagnosis based on clinical presentation alone can be challenging because of the wide variety and often nonspecific symptoms that are associated with LVV. This has prompted the development of novel diagnostic tools to aid patient management, in particular advanced vascular imaging approaches. New therapies targeting specific immune pathways are now becoming available to improve outcomes while limiting the side effects associated with traditional glucocorticoid treatment. Advances in molecular imaging techniques may also enhance our ability to objectively monitor disease and treatment response in patients with LVV. Ongoing research aims to better understand the underlying mechanisms and to develop better targeted therapies for LVV, and to improve patient assessment and life time management. This narrative review will provide an in-depth update on current challenges and future trends in LVV, enhancing our understanding of its pathogenesis, diagnostic features, and management strategies, including disease- and treatment-related cardiovascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Giant Cell ArteritisTakayasu ArteritisHumansFemale

Stichwörter der Autor:innen

Takayasu arteritisdiagnosticsgiant cell arteritislarge vessel vasculitismanagementpathogenesis

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology (M.S., K.S.M.v.d.G., E.B.), University of Groningen, University Medical Centre Groningen, The Netherlands.
  • Department of Medical Microbiology and Infection Prevention (R.D.R.), University of Groningen, University Medical Centre Groningen, The Netherlands.
  • British Heart Foundation/University Centre for Cardiovascular Science, University of Edinburgh, United Kingdom (N.D., M.R.D.).
  • National Heart & Lung Institute, Imperial College London, United Kingdom (T.Y.).
  • Department of Rheumatology, Hammersmith Hospital, Imperial College Healthcare National Health Service Trust, London, United Kingdom (T.Y.).
  • Rheumatology Division, Department of Medicine, Escola Paulista de Medicina-Universidade Federal de São Paulo, Brazil (A.W.S.d.S.).

ORCID-Profile: Maria Sandovici, Kornelis S M van der Geest, Rosanne D Reitsema, Neeraj Dhaun, Taryn Youngstein, Alexandre Wagner Silva de Souza, Marc R Dweck, Ellen Hendrikse, Andor W J M Glaudemans, Elisabeth Brouwer

Förderung

  • Intramural NIH HHS

Zitieren

APA

Sandovici, M., van der Geest, K. S. M., Reitsema, R. D., Dhaun, N., Youngstein, T., de Souza, A. W. S., Grayson, P. C., Nielsen, B. D., Dweck, M. R., Hendrikse, E., Glaudemans, A. W. J. M., Brouwer, E., & Slart, R. H. J. A. (2026). Challenges and Future Trends in Large Vessel Vasculitis. Circulation, 153(25), 2064-2083. https://doi.org/10.1161/circulationaha.125.077491

Vancouver

Sandovici M, van der Geest KSM, Reitsema RD, Dhaun N, Youngstein T, de Souza AWS, et al. Challenges and Future Trends in Large Vessel Vasculitis. Circulation. 2026;153(25):2064-2083. doi:10.1161/circulationaha.125.077491

BibTeX
@article{Sandovici2026,
  author = {Sandovici, Maria and van der Geest, Kornelis S M and Reitsema, Rosanne D and Dhaun, Neeraj and Youngstein, Taryn and de Souza, Alexandre Wagner Silva and Grayson, Peter C and Nielsen, Berit D and Dweck, Marc R and Hendrikse, Ellen and Glaudemans, Andor W J M and Brouwer, Elisabeth and Slart, Riemer H J A},
  title = {Challenges and Future Trends in Large Vessel Vasculitis},
  journal = {Circulation},
  year = {2026},
  volume = {153},
  number = {25},
  pages = {2064--2083},
  doi = {10.1161/circulationaha.125.077491}
}
Kostenlos starten →